Do you have knee pain? Have you been diagnosed with osteoarthritis (OA) of the knee? You may be eligible to participate in a clinical trial with Dr. Jack Farr, OrthoIndy knee preservation and cartilage restoration specialist.
HYMOVIS® is an FDA-approved treatment of pain in OA of the knee in patients who do not get adequate pain relief from simple pain relivers like acetaminophen or from exercise and physical therapy. HYMOVIS® treatment consists of two weekly hyaluronic acid injections to the knee joint to relieve knee pain caused by knee arthritis.
This trial will assess the safety and performance of HYMOVIS® combined with a physical exercise program as compared to physical exercise alone for reducing pain due to OA of the knee. It is anticipated that this study treatment will provide relief of pain due to OA of the knee, but this benefit is not guaranteed.
Voluntary participation will last approximately six to nine months, with multiple clinic visits during this time.
You may be eligible to participate if you:
- Are between 21 to 60 years old
- Are physically active
- Have persistent knee pain lasting at least three months
If you decide to participate and are eligible, you will be asked to complete:
- Screening procedures, including covered X-Ray and health assessments
- Reports on medication use, pain levels and other assessments
- Between five to seven clinic visits
You will be compensated for incidental expenses to cover out of pocket and travel expenses for follow-up visits.